M84.575S Pathological fracture in neoplastic disease, left foot, sequela

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Left Foot, Sequela (ICD-10-CM: M84.575S)

Summary

This condition describes a pathological fracture in the left foot resulting from underlying neoplastic (cancerous) disease, with residual effects or complications persisting after the acute phase of the fracture. The fracture occurs due to weakened bone structure caused by cancer, rather than direct trauma, and the sequela indicates ongoing consequences of the fracture related to the neoplastic process.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the left foot, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode bone in these areas, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the foot.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to foot sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Persistent pain or discomfort in the left foot, even after initial fracture healing.
• Limited mobility or functional impairment due to residual bone damage.
• Visible deformity or instability in the affected foot.
• Possible swelling or tenderness in the area.
• Reduced weight-bearing capacity or gait abnormalities.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., X-rays, MRI, or CT scans), and correlation with the patient's cancer history. Imaging may reveal residual bone damage, non-union, or malunion of the fracture, along with evidence of underlying neoplastic disease. Biopsy or prior cancer documentation may be used to confirm the neoplastic cause. The sequela status is determined by the presence of long-term effects following the fracture.

Treatment Options

Treatment focuses on managing residual effects and preventing further complications. This may include pain management, physical therapy to improve function, orthopedic interventions (e.g., bracing or surgery for stabilization), and ongoing cancer treatment to address the underlying neoplastic disease. Rehabilitation aims to restore mobility and reduce disability.

Prognosis and Follow-Up

Prognosis depends on the extent of residual bone damage, the type and stage of the underlying cancer, and the effectiveness of treatment. Regular follow-up is essential to monitor for complications, assess functional recovery, and adjust management as needed. Long-term surveillance for cancer progression or additional fractures may be required.

Complications

• Chronic pain or disability due to persistent bone damage.
• Non-union or malunion of the fracture.
• Increased risk of future fractures in the affected foot.
• Progression of the underlying neoplastic disease.
• Reduced quality of life due to mobility limitations.

Lifestyle & Prevention

• Maintain regular follow-up with healthcare providers to monitor cancer and bone health.
• Engage in prescribed physical therapy to optimize function and strength.
• Use supportive footwear or orthotics to reduce stress on the affected foot.
• Follow cancer treatment plans to control the underlying neoplastic disease.
• Avoid high-impact activities that may exacerbate residual bone damage.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden, severe pain in the left foot.
• New or worsening swelling, deformity, or instability.
• Signs of infection (e.g., redness, warmth, or fever).
• Difficulty bearing weight or walking.
• Changes in sensation or circulation in the foot.

Tips for Medical Coders

This code (M84.575S) is used for a pathological fracture in neoplastic disease of the left foot, sequela. Document the residual effects or complications of the fracture, such as chronic pain, deformity, or functional impairment, to support the sequela designation. Ensure the underlying neoplastic disease is clearly documented, as this code requires a causal relationship between the cancer and the fracture. Verify that the encounter is for managing long-term consequences rather than acute fracture care.